Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

Objective. Gefitinib often induces liver damage. A few reports have described that the subsequent administration of erlotinib was associated with less hepatotoxicity, but the safety and efficacy of this treatment are still not fully investigated. Therefore, we evaluated retrospectively the patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer Int
Main Authors: Yano, Yukihiro, Namba, Yoshinobu, Mori, Masahide, Nakazawa, Yukie, Nashi, Ayumi, Kagami, Shinichi, Niinaka, Manabu, Yoneda, Tsutomu, Kimura, Hiromi, Yamaguchi, Toshihiko, Yokota, Soichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437396/
https://ncbi.nlm.nih.gov/pubmed/26316933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/354657
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados